Publicaties

Jacobs A, Stalpers-Konijnenburg SC, DeJong CA, Marijnissen RM.  2016.  Chronic Stimulant Use: An Upcoming Cause of Neurocognitive Disorder in Later Life? Clinical Medical Reviews and Case Reports. 3(1)

van Duijvenbode N, Didden R, VanDerNagel JEl, Korzilius HPlm, Engels RCme.  2016.  Cognitive deficits in problematic drinkers with and without mild to borderline intellectual disability.. J Intellect Disabil. :1744629516664840.

Groenman AP, Greven CU, van Donkelaar MMJ, Schellekens A, van Hulzen KJE, Rommelse N, Hartman CA, Hoekstra PJ, Luman M, Franke B et al..  2016.  Dopamine and serotonin genetic risk scores predicting substance and nicotine use in attention deficit/hyperactivity disorder.. Addict Biol. 21(4):915-23.

Markus W.  2016.  EMDR interventions in addiction.. Journal of EMDR Practice and Research. 11(1)

Brunt TM, van Noorden M, Kamal RM, Dijkstra BAG, DeJong CA.  2016.  Epidemiology of Gamma-hydroxybutyrate (GHB) use and misuse and characteristics of GHB-dependent inpatients. The Neuropathology Of Drug Addictions And Substance Misuse.

van Noorden M, Kamal RM, Dijkstra BAG, Brunt TM, DeJong CA.  2016.  Gamma-Hydroxybutyrate Abuse and Dependence . Neuropathology of Drug Addictions and Substance Misuse . Volume 2: Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants, and International Aspects

Mackey S, Kan K-J, Chaarani B, Alia-Klein N, Batalla A, Brooks S, Cousijn J, Dagher A, de Ruiter M, Desrivieres S et al..  2016.  Genetic imaging consortium for addiction medicine: From neuroimaging to genes.. Prog Brain Res. 224:203-23.

Beurmanjer H., Asperslag E.M., Verbrugge CAG, Oliemeulen L.E.A.P., Schellekens A, DeJong CA, Dijkstra BAG.  2016.  GHB afhankelijkheid: ziektepercepties en behandelingsbehoeftes.

Goudriaan A., De Fuentes-Merillas L.  2016.  Gokstoornis. Psychopathologie: Oorzaken, diagnostiek en behandeling. Deel 16 Middelgerelateerde en verslavingsstoornissen:801-816.

De Haan L, de Haan HA, DeJong CA.  2016.  Interpersonal Relating, Risk-Taking Behavior and Alcohol Use in Young Adults: in Editors. 2016, Palgrave MacMillan: Londo. Relating Theory-Clinical and Forensic Applications. Eds: Birtchnell, J, Newberry, M, and Kalaitzaki, AE.

Bruijnen CJWH, Kessels RP, Dijkstra BAG, Walvoort SJW, Wester AJ, DeJong CA.  2016.  Montreal Cognitive Assessment - Dutch (MoCA-D): een cognitieve screener in de Nederlandse reguliere verslavingszorg.

Kamal RM, van Noorden M, Franzek E.J., Dijkstra BAG, Loonen AJ, DeJong CA.  2016.   The Neurobiological Mechanisms of Gamma-Hydroxybutyrate Dependence and Withdrawal and Their Clinical Relevance: A Review. Neuropsychobiology. 73

Kamal RM, Dijkstra BAG, van Oene GH de Weert, van Duren JAM, DeJong CA.  2016.  Psychiatric Comorbidity, Psychological Distress and Quality of Life in Gamma-hydroxybutyrate (GHB) Dependent Patients.. J Addict Dis.

Kiewik M, VanDerNagel JEl, Kemna LEM, Engels RCME, DeJong CA.  2016.  Substance use prevention program for adolescents with intellectual disabilities on special education schools: a cluster randomised control trial.. J Intellect Disabil Res. 60(3):191-200.

Kiewik M, VanDerNagel JEl, Kemna L.E.M., Engels RCME, DeJong CA.  2016.  Substance use prevention program for adolescents with intellectual disabilities on special education schools: A cluster randomised control trial. Journal of Intellectual Disability Research. 60(3):191–200.

DeJong CA, De Fuentes-Merillas L, van de Werken F..  2016.  The US: An unidimentional measure of couple satisfaction. Relating Theory: Clinical, Forensic and Other Applications.

DeJong CA, DeFuentes-Merillas L, VandeWerken F, Birtchnell J.  2016.  The US as a Couple Questionnaire (US). A Unidimensional Measure of Couple Satisfaction. Relating Theory-Clinical and Forensic Applications. Eds: J. Birtchnell, M. Newberry, and A.E. Kalaitzaki.

Oliemeulen L.E.A.P., van de Ven P, Verbrugge CAG.  2016.  Wat is de visie op herstel bij verslaafde clienten . Verslaving anders bekijken.

Postel MG, Huurne ED ter, de Haan HA, van der Palen J, DeJong CA.  2015.  A 9-month follow-up of a 3-month web-based alcohol treatment program using intensive asynchronous therapeutic support.. Am J Drug Alcohol Abuse. 41(4):309-16.

Middeldorp J, Smit R, Post H, Koerts J, van Oene GH de Weert.  2015.  Aandacht voor somatiek bij verslaafden. Verslaving. 11

DeJong CA, Luycks L.  2015.  Addiction medicine training in the Netherlands. el-Guebaly N, Carrà G, Galanter M (Eds) Textbook of Addiction Treatment: International Perspectives. . XII

Batalla A, Bargalló N, Gassó P, Molina O, Pareto D, Mas S, Roca JM, Bernardo M, Lafuente A, Parellada E.  2015.  Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls.. Transl Psychiatry. 5:e626.

Kok T, de Haan HA, van der Meer M, Najavits L, DeJong CA.  2015.  Assessing traumatic experiences in screening for PTSD in substance use disorder patients: What is the gain in addition to PTSD symptoms? Psychiatry Res. 226(1):328-32.

López-Pelayo H, Batalla A, Balcells MM, Colom J, Gual A.  2015.  Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments. Psychol Med. 45(6):1121-33.

Kamal RM, Qurishi R, DeJong CA.  2015.  Baclofen and γ-Hydroxybutyrate (GHB), a Dangerous Combination.. J Addict Med. 9(1):75-7.